Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

por Covelli, Henry, Pek, Bonavuth, Schenkenberger, Isabelle, Scott-Wilson, Catherine, Emmett, Amanda, Crim, Courtney
Publicado 2015

Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness

por Horne, Benjamin D, Ali, Rehan, Midwinter, Dawn, Scott-Wilson, Catherine, Crim, Courtney, Miller, Bruce E, Rubin, David B
Publicado 2021

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

por Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney
Publicado 2017